Denis Chem Lab Limited (DENISCHEM) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE051G01012
Key metrics
- Market Cap
- ₹103 Cr
- P/E Ratio
- 12.87
- EPS
- 5.75
- Book Value
- 65.99
- P/B Ratio
- 1.12
- ROE
- 9.18%
- ROCE
- 12.7%
- Debt / Equity
- 0.05
- Net Margin
- 4.63%
- Revenue Growth
- 4.86%
- Profit Growth
- 4.13%
- Dividend Yield
- 3.46%
- 52W High
- ₹103.00
- 52W Low
- ₹56.10
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Denis Chem Lab Limited
Denis Chem Lab Limited, a pharmaceutical company, engages in the manufacturing and marketing of sterile intravenous injectable products for human and veterinary use in India. The company's products include antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-anaerobic injections, anti-pyretic injections, irrigation and dialysis solutions, etc. It also provides contract manufacturing services for third parties, as well as manufactures and sells transfusion solutions in bottles. The company serves government and semi-government institutions, hospitals and nursing homes, aided agencies, and defense sector. It also exports its products to Sri Lanka, Vietnam, Cambodia, Somalia, Nepal, Ivory Coast, etc. The company was incorporated in 1980 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Promoter Holding
- 75.43%
The full Denis Chem Lab Limited analysis
Create a free account to open the complete DENISCHEM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.